CLDP organized the consultations in close cooperation with the US Food and Drug Administration, MEPI and Tunisia’s Ministry of Health/Directorate of Pharmacy. The consultations focused on content and development of US safety and regulation in the pharmaceutical sector. To that end, consultations included meetings with representatives from the US Department of Commerce, the US Food and Drug Administration, the office of the United States Trade Representative, and public and private educational and business organizations involved in the process of safety and regulation of the pharmaceutical sector in the United States.